Subungual squamous cell carcinoma after organ transplantation.
It is accepted that immunosuppressant therapy after organ transplantation is associated with an increase risk of neoplasm. Subungual squamous cell carcinoma of the toe is a rare condition and has not previously been reported, to our knowledge, in patients undergoing immunosuppressant therapy. The objective of this case study is to report the clinical and histopathologic findings and the multidisciplinary treatment approach for a case of subungual squamous cell carcinoma of the toe in an organ transplant recipient undergoing immunosuppressant drug therapy.
Sung
Wenjay
W
Podiatric Residency Program PMS-36, University of Pittsburgh Medical Center Mercy, Pittsburgh, PA 15219, USA. sungw@upmc.edu
Sam
Hakeem
H
Deleyiannis
Frederic W B
FW
D000368:Aged; D001913:Bowen's Disease / Q000175:diagnosis; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000601:surgery; D003937:Diagnosis, Differential; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D015580:Mohs Surgery; D009260:Nail Diseases / Q000473:pathology* / Q000601:surgery; D009361:Neoplasm Invasiveness; D012878:Skin Neoplasms / Q000473:pathology*; D014034:Toes / Q000473:pathology / Q000601:surgery
D007166:Immunosuppressive Agents